Authors: Sabia, H Prasad, P Smith, HT Stoltz, RR Rothenberg, P

Citation: H. Sabia et al., Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia, J CARDIO PH, 37(5), 2001, pp. 502-511

Authors: Viegas, TX Omura, GA Stoltz, RR Kisicki, JT

Citation: Tx. Viegas et al., In pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral dosesin healthy volunteers (vol 40, pg 410, 2000), J CLIN PHAR, 40(6), 2000, pp. 664-664

Authors: Viegas, TX Omura, GA Stoltz, RR Kisicki, J

Citation: Tx. Viegas et al., Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses inhealthy volunteers, J CLIN PHAR, 40(4), 2000, pp. 410-420

Authors: Grasela, DM Stoltz, RR Barry, M Bone, M Mangold, B O'Grady, P Raymond, R Haworth, SJ

Citation: Dm. Grasela et al., Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis, ANTIM AG CH, 44(8), 2000, pp. 2149-2153